Epidarex Capital
epidarex.com Direct investor
Epidarex Capital is a transatlantic venture capital firm that invests in early-stage life science and health technology companies in emerging research hubs in the UK and US. They provide seed and Series A funding, often to university spin-outs, and focus on building companies with transformative science.
Epidarex Capital is a venture capital firm headquartered in Edinburgh, United Kingdom. It invests directly in companies, from seed to Series A, in life science, health technology, biotechnology and pharmaceuticals. 27 portfolio companies, as it reports.
“EPIDAREX IS A TRANSATLANTIC VENTURE CAPITAL FIRM LED BY A DIVERSE TEAM OF EARLY-STAGE INVESTORS BUILDING BREAKTHROUGH LIFE SCIENCE COMPANIES IN EMERGING HUBS”
— Epidarex Capital, own website
- Layer
- Direct investor
- Type
- Venture capital
- Headquarters
- Edinburgh, United Kingdom
- Invests in
- US, UK
- Sectors
- life science, health technology, biotechnology, pharmaceuticals, medical devices, health tech
- Portfolio
- 27 companies
Team, as Epidarex Capital publishes it
- A. Sinclair Dunlop Managing Partner
- Kyparissia Sirinakis Founding Partner
- Elizabeth Roper Ph.D. Managing Partner
- Peter Finan Ph.D. Managing Partner
- Mary Canning Ph.D. Partner
- Lori Krim Gough Ph.D. Partner
- Henning Steinhagen Ph.D. Venture Partner
- Anthony Voveris Chief Financial Officer
- Matthew Miessau Principal
- Victor Pong Ph.D. Associate
- Melissa Lezameta Ph.D. Senior Associate
- Bridget Harris Director of Operations
Names and roles exactly as listed on epidarex.com. Nothing else about these people is recorded.
Most shared portfolio companies with
Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 22 investors with a shared portfolio company. A shared company is not proof they invested together in the same round.
- BioGeneration Ventures 3 shared companies: mironid.com, epsilogen.com, dunad.co.uk
- Sofinnova 2 shared companies: mironid.com, nodthera.com
- Novartis Venture Fund 2 shared companies: epsilogen.com, enterprisetherapeutics.com
- Boehringer Ingelheim Venture Fund 2 shared companies: libratherapeutics.com, topas-therapeutics.com
- AlbionVC 1 shared company: epsilogen.com
- M Ventures 1 shared company: theolytics.com
- Oxford Science Enterprises 1 shared company: theolytics.com
- Sound Bioventures 1 shared company: theolytics.com
- Avoro Capital Advisors LLC 1 shared company: apellis.com
- CoLift LLC 1 shared company: apellis.com
and 12 more — the graph.
Where this comes from
Every fact above was read from a page Epidarex Capital publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.
- https://epidarex.com/name, is_investor, type, hq_country, hq_city, description, status, thesis_quote
- https://epidarex.com/strategy/layer, stage_min, stage_max, sectors, thesis_quote, thesis_quote_page
- https://epidarex.com/about-us/invests_in_geographies, people
- https://epidarex.com/portfolio/portfolio_count
Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.
Record 935 · added 2026-08-28 · link last verified 2026-10-27 · confidence high
Similar investors
- AbingworthVenture capital · Seed – Growth · London, United Kingdom
- AlbionVCVenture capital · Pre-seed – Growth · London, United Kingdom
- ALSA VenturesVenture capital · London, United Kingdom
- GrayBella CapitalVenture capital · Series A – Series C+ · London, United Kingdom
- Monograph Capital Advisors (UK) LLPVenture capital · Seed – Series C+ · London, United Kingdom
- NCL Technology VenturesVenture capital · London, United Kingdom